Project Grant R21DE034067

Award Date 4/8/25
Completion Date 3/31/27
Dollars Obligated $237K
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Minnesota, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), totaling $557,606.00, supports research aimed at advancing the understanding of periodontal stem cells and their regulation for more predictable and efficient periodontal tissue regeneration. The key research objectives are to: 1) characterize the properties of periodontal crestal stem cells (PCSCs) and their activation by...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $148,568 Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) to the Regents of the University of Michigan. The 18-month project aims to develop innovative biomarkers and a machine learning classifier to improve the characterization and monitoring of periodontal inflammation using quantitative ultrasound and image texture analysis techniques. Specifically, the research will investigate...
This Project Grant award, totaling $446,875.00, was provided by the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports research to investigate the role of a novel G protein-coupled receptor (MRGPRX2/MRGPRB2) expressed on mast cells and its contribution to the development of periodontal disease. The research aims to develop humanized mouse models to study the impact of this receptor and its...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $873,546 Project Grant under the Oral Diseases and Disorders Research Program (CFDA 93.121) to the University of Texas Health Science Center at Houston (UTHealth). The grant aims to develop a biomaterial-enhanced system for targeted localization of engineered probiotic bacteria (Limosilactobacillus reuteri) that secrete the anti-inflammatory cytokine interleukin-10 (IL-10) to treat experimental periodontitis. The key...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $432,209 Project Grant under the Oral Diseases and Disorders Research (CFDA 93.121) program to the University of California, Los Angeles (UCLA) for a 2-year period starting on August 1, 2023. The funding supports research to investigate the role of the CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus on periodontitis. Specifically, the research aims to further elucidate the role of CXCL10 in the...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $995,000.00 to the ADA Forsyth Institute, Inc. (doing business as The Forsyth Institute) to conduct research on the mechanisms of peroxisome proliferator-activated receptor-alpha (PPAR-α) regulation in periodontitis. The research aims to determine if PPAR-α agonist treatment can modulate macrophage polarization to...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) totals $588,952 and will run from April 2025 to March 2030. The funding will support the development and optimization of a bio-inspired tubular matrix scaffold to guide the formation of periodontal ligament (PDL) principal fibers and rebuild the microenvironment for the regeneration of Sharpey's fibers, which are critical for...
This $429,000 federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121) will fund research on differential responses of jawbone versus long bone cells to bone growth factor signaling and mechanical loading. The research aims to provide novel molecular insights into unique mechanisms governing jawbone health, with the goal of improving physical and pharmacological interventions for...
This Project Grant award of $1,839,472 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to define dysbiosis and identify microbial changes that are predictive of periodontitis progression and stability. The project aims to utilize the biobank and longitudinal data from the previous "Biomarkers of Periodontal Disease Progression (BPDP)" study to examine microbial,...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR) under CFDA program 93.121 Oral Diseases and Disorders Research provides $226,500.00 to The Medical University of South Carolina to investigate the role of the CD38 signaling pathway in regulating aging-associated immune responses induced by oral bacterial pathogens. The goal is to define how oral pathogens like Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis affect aging-associated...

This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), supports research to investigate the role of the lysine-specific demethylase 1 (LSD1) enzyme in regulating osteoclast activity and bone loss during periodontal disease. The $236,756 award to the Regents of the University of Minnesota will fund a 2-year research project to gain mechanistic insights into how LSD1 deficiency affects osteoclast function and prevents bone loss in a ligature-induced periodontitis model. The research will utilize bulk RNA-seq, ATAC-seq, and single-cell sequencing techniques to examine skeletal site-specific changes in mandible-derived pre-osteoclasts and innate immune cell responses. The goal is to elucidate the epigenetic mechanisms by which LSD1 regulates inflammatory cytokine-induced osteoclast differentiation, with the potential to identify promising therapeutic targets for treating periodontal bone loss.

Generated 4/29/25, 3:34 AM